Compare VSTM & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSTM | AVK |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 558.9M |
| IPO Year | 2011 | 2003 |
| Metric | VSTM | AVK |
|---|---|---|
| Price | $5.50 | $11.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 138.9K |
| Earning Date | 03-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $282.16 | N/A |
| Revenue Next Year | $72.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $4.01 | $9.75 |
| 52 Week High | $11.25 | $13.10 |
| Indicator | VSTM | AVK |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 27.43 |
| Support Level | $4.01 | N/A |
| Resistance Level | $6.79 | $12.94 |
| Average True Range (ATR) | 0.40 | 0.19 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 12.50 | 11.74 |
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.